Zobrazeno 1 - 10
of 56
pro vyhledávání: '"B Vens-Cappell"'
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 47:391-401
Objective: To compare the steady-state pharmacokinetics and pharmacodynamics following multiple subcutaneous administration of a new erythropoiesis stimulating agent (HX575, Binocrit ® , Sandoz GmbH, Holzkirchen, Germany) with that of epoetin beta (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cf982d00fd96f7f1ddfdf3a512fc014
https://doi.org/10.5414/cpp47391
https://doi.org/10.5414/cpp47391
Publikováno v:
Geburtshilfe und Frauenheilkunde. 65:584-589
Purpose: The study was performed to evaluate the efficacy and safety of locally applied estradiol cream (Linoladiol® N) on vaginal atrophy in postmenopausal women in fractionated use. Material and Methods: In a randomized, double-blind, placebo-cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54c850a38d2559545d299e754ae401c4
https://doi.org/10.1055/s-2005-865703
https://doi.org/10.1055/s-2005-865703
Publikováno v:
UroToday International Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7530927d40e21edc8b91765bb2862710
https://doi.org/10.3834/uij.1939-4810.2008.06.104
https://doi.org/10.3834/uij.1939-4810.2008.06.104
Publikováno v:
Scopus-Elsevier
Dihydroergotoxine mesylate (DHETM, CAS 8067-24-1), the combination of the mesylates of four dihydrogenated ergot alkaloid derivatives (dihydroergocornine, dihydroergocristine, alpha-dihydroergocryptine and beta-dihydroergocryptine), is used mainly fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a99c5879aca39fba8695897829fc7cc
https://pubmed.ncbi.nlm.nih.gov/11215321
https://pubmed.ncbi.nlm.nih.gov/11215321
Publikováno v:
International journal of clinical pharmacology and therapeutics. 38(8)
Objective A bioavailability study using three different doses was designed to assess the dose proportionality of a new multiple-unit sustained release formulation of sodium valproate. SUBIECTS AND METHODS: The study was performed using an open, three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1fc3bafa34193f6ddd0534b0b1f8f9f
https://pubmed.ncbi.nlm.nih.gov/10984013
https://pubmed.ncbi.nlm.nih.gov/10984013
Publikováno v:
Arzneimittel-Forschung. 50(7)
Aim: The study was carried out to explore the potential for pharmacokinetic interaction of a single oral dose of alpha-dihydroergocryptine (CAS 14271-05-7, DHEC, Almirid(R)) with digoxin. Methods: The serum pharmacokinetics of digoxin were analysed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eca0c5454b5d74b2aff8cfbe8fbcf4c4
https://pubmed.ncbi.nlm.nih.gov/10965414
https://pubmed.ncbi.nlm.nih.gov/10965414
Publikováno v:
International journal of clinical pharmacology and therapeutics. 37(2)
Two bioavailability studies were conducted in healthy male volunteers to determine the absorption characteristics of a new dosage form of sodium valproate consisting of sustained release pellets in a hard gelatine capsule.To obtain first data on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::938a772a89d9d54a1bab6acca9f5126e
https://pubmed.ncbi.nlm.nih.gov/10082174
https://pubmed.ncbi.nlm.nih.gov/10082174
Publikováno v:
Arzneimittel-Forschung. 48(12)
Two studies on the rate and extent of bioavailability of fluoride from a single dose of oral preparations of sodium monofluorophosphate (Na2FPO3) combined with calcium supplement were conducted according to a cross-over design on 18 (Study 1) and 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a0e49fc960daf256094a7e16f8eb6fde
https://pubmed.ncbi.nlm.nih.gov/9893933
https://pubmed.ncbi.nlm.nih.gov/9893933
Publikováno v:
Arzneimittel-Forschung. 48(3)
The pharmacokinetic patterns of estradiol (CAS 50-28-2) and of estrone (CAS 53-16-7) were investigated in 18 women in natural or surgical menopause during the application of a new estradiol transdermal patch with active matrix and without absorption
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2477fae1b1ed2abfadcad8bc4dc38939
https://pubmed.ncbi.nlm.nih.gov/9553686
https://pubmed.ncbi.nlm.nih.gov/9553686
Publikováno v:
Arzneimittel-Forschung. 46(8)
The estradiol (CAS 50-28-2, E2) and estrone (CAS 53-16-7, E1) concentrations in blood were investigated during a 3-week twice weekly application of an E2 transdermal patch, or daily oral administration of E2 tablets. The transdermal patch (Dermestril
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5b06227d40e3921ae8c1b88577492e6f
https://pubmed.ncbi.nlm.nih.gov/9125276
https://pubmed.ncbi.nlm.nih.gov/9125276